beta-amyloid drug
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| beta-amyloid | biomarker_for | Alzheimer’s disease | — | 1 |
| ImageJ | associated_with | beta-amyloid | — | 1 |
Mentioned in (12)
Papers in which this entity is mentioned.
- Mitochondria-dependent phase separation of disease-relevant proteins drives pathological features of age-related macular degeneration. (2021)
- Neurotrophins in the Brain: Interaction With Alcohol Exposure During Development. (2017)
- ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease. (2017)
- Effect of Neuroinflammation on Synaptic Organization and Function in the Developing Brain: Implications for Neurodevelopmental and Neurodegenerative Disorders. (2017)
- Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes. (2016)
- Genetic Restoration of Plasma ApoE Improves Cognition and Partially Restores Synaptic Defects in ApoE-Deficient Mice. (2016)
- Direct Transcriptional Effects of Apolipoprotein E. (2016)
- New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy. (2014)
- Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. (2012)
- Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration. (2010)
- Maternal immune activation alters fetal brain development through interleukin-6. (2007)
- Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain. (2001)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| beta-amyloid | drug | 12 | 15 |